RTSM (Randomization and Trial Supply Management)

RTSM stands for Randomization and Trial Supply Management. It refers to the specific category of clinical trial technology — not a general process — responsible for assigning enrolled subjects to a treatment arm and, in most implementations, for managing the physical drug supply that assignment depends on: kit-level inventory, expiry tracking, and automatic resupply to sites. In current industry usage RTSM is functionally synonymous with IRT (Interactive Response Technology), the broader umbrella term for the same platform category; the two names emphasize different halves of the same system (RTSM foregrounds supply management, IRT is the more general label covering randomization, blinding, and supply together).

What an RTSM/IRT platform actually does

A modern RTSM/IRT system is a purpose-built software platform, typically accessed by site staff through a web portal (historically also by phone, in its IVRS-era predecessor), that performs some or all of the following within one integrated tool:

• Randomization — assigning each enrolled subject to a treatment arm according to the protocol’s randomization scheme (simple, block, stratified, or minimization-based), without human discretion introducing bias at the point of assignment.
• Blind maintenance and emergency unblinding — in blinded designs, restricting visibility of a given subject’s actual treatment assignment to authorized roles only, while providing a defined, auditable pathway for an investigator to break the blind in a genuine safety emergency.
• Kit- or dose-level inventory management — tracking which specific physical kit, bottle, or dose number is assigned to which subject at which visit, so a site dispenses the protocol-correct unit every time and the record ties back to a specific lot and expiry date.
• Supply forecasting and automatic resupply — using real-time enrollment and dispensing data to trigger resupply shipments to a site or regional depot before local stock runs out or expires, reducing both stock-outs and wasted excess/expired inventory.

Because the platform holds the randomization code itself, its validation, access controls, and audit trail are within direct regulatory scope — the same electronic-records discipline that applies to a trial’s clinical database (21 CFR Part 11 in the US) applies to the system controlling the blind.

RTSM/IRT vs. EDC vs. CTMS

These three system categories are frequently confused because they are all “clinical trial software” used on the same study, sometimes by the same site staff in the same session — but they solve different problems and are not interchangeable:

• RTSM/IRT answers “which arm is this subject in, and which physical kit do they get” — it owns randomization and (where applicable) supply.
• EDC (Electronic Data Capture) answers “what clinical data was collected for this subject at this visit” — case report form data, lab values, adverse events. It has no role in treatment assignment or physical inventory.
• CTMS (Clinical Trial Management System) answers operational and administrative questions — site and study status, monitoring visit tracking, budgets and payments, regulatory document tracking — across a sponsor’s or site’s whole trial portfolio, not a single subject’s assignment or supply.

Larger eClinical platform vendors increasingly offer RTSM, EDC, and CTMS as integrated modules of one suite specifically so subject and visit data can flow between them without manual re-entry, but the underlying functional distinction — what each module is actually responsible for — still holds even when the systems are unified under one vendor or one login.

Terminology: IRT vs. IWRS vs. IVRS vs. RTSM

These terms describe overlapping generations and emphases of the same underlying technology, and in current industry usage are largely treated as synonyms:

• IVRS (Interactive Voice Response System) — the original telephone-based version of the technology.
• IWRS (Interactive Web Response System) — its web-based successor.
• IRT (Interactive Response Technology) — the current, broader umbrella term covering randomization, blinding, and supply functions together, regardless of access channel.
• RTSM (Randomization and Trial Supply Management) — commonly used interchangeably with IRT, with the name itself emphasizing the supply-management half of the platform.

Vendors and market

RTSM/IRT is a mature, vendor-served software category rather than something sponsors typically build in-house. Established and widely used platforms in this space include Oracle’s Clinical One, IQVIA (which incorporates the formerly independent Cenduit), Medidata’s Rave RTSM, Signant Health, Veeva Systems, 4G Clinical, Suvoda, YPrime, and Almac Clinical Technologies, among others — sponsors typically select a platform (or an integrated module within a broader eClinical suite) based on study complexity, required integrations, and deployment speed, and the specific vendor landscape changes as the market consolidates.

Related CASRAI resources

RTSM/IRT sits within the broader IMP supply chain covered in CASRAI’s guide to Clinical Trial Supply Management, which addresses GMP manufacturing, packaging and labeling, cold-chain logistics, and site-level drug accountability alongside the IRT/RTSM system itself. See also the dictionary entries for Electronic Data Capture (EDC), Randomized Controlled Trial (RCT), 21 CFR Part 11, and Clinical Trials Unit (CTU); and the Clinical Research Administration cluster hub for the wider trial-operations picture.